Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry.
Ezio ZanonSamantha PascaBerardino PollioElena SantagostinoSilvia LinariAnnarita TagliaferriCristina SantoroAngiola RocinoRenato MarinoBrigida AruAlessandra BorchielliniSergio SiragusaAntonio CoppolaPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2019)
Our Registry showed that the use of moroctocog-alpha in the setting of ITI was effective and safe also in a population of patients with high-titre inhibitors, presenting one or more risk factors for poor ITI prognosis.